Early use of nitazoxanide in mild COVID-19 disease: randomised, placebo-controlled trial.
Rocco PRM, Silva PL, Cruz FF, Melo-Junior MAC, Tierno PFGMM, Moura MA, De Oliveira LFG, Lima CC, Dos Santos EA, Junior WF, Fernandes APSM, Franchini KG, Magri E, de Moraes NF, Gonçalves JMJ, Carbonieri MN, Dos Santos IS, Paes NF, Maciel PVM, Rocha RP, de Carvalho AF, Alves PA, Proença-Módena JL, Cordeiro AT, Trivella DBB, Marques RE, Luiz RR, Pelosi P, Lapa E Silva JR; SARITA-2 investigators.
Rocco PRM, et al. Among authors: rocha rp.
Eur Respir J. 2021 Jul 8;58(1):2003725. doi: 10.1183/13993003.03725-2020. Print 2021 Jul.
Eur Respir J. 2021.
PMID: 33361100
Free PMC article.
Clinical Trial.